Nuo Therapeutics, Inc.
AURX
$1.63
$0.00460.28%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 44.55% | 22.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 44.55% | 22.66% | |||
| Cost of Revenue | 31.74% | 40.05% | |||
| Gross Profit | 48.84% | 17.80% | |||
| SG&A Expenses | 7.61% | 18.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.98% | 20.06% | |||
| Operating Income | 12.49% | -18.42% | |||
| Income Before Tax | 12.92% | -50.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.92% | -50.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.92% | -50.21% | |||
| EBIT | 12.49% | -18.42% | |||
| EBITDA | 13.81% | -18.15% | |||
| EPS Basic | 12.58% | -51.43% | |||
| Normalized Basic EPS | 13.00% | -19.05% | |||
| EPS Diluted | 12.58% | -51.43% | |||
| Normalized Diluted EPS | 13.00% | -19.05% | |||
| Average Basic Shares Outstanding | 0.01% | -0.76% | |||
| Average Diluted Shares Outstanding | 0.01% | -0.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||